TiUltra Implant Study
Comparison of Early Healing Dynamics Between NobelActive S TiUltra and NobelReplace CC Ti Unite Implants Using Resonance Frequency Analysis: A Prospective Clinical Study
This prospective clinical study will compare early healing and implant stability between two Nobel Biocare dental implant systems, NobelActive S TiUltra and NobelReplace CC TiUnite. Approximately 30 implants will be randomly assigned to one of the two implant groups and followed for 12 weeks after placement. Implant stability will be assessed using resonance frequency analysis at implant placement and at approximately 2, 4, 6, 8, and 12 weeks. Clinical healing, radiographic findings, and other treatment-related outcomes will also be evaluated during the follow-up period.
研究概览
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Hanae Saito
- 电话号码:410-706-3646
- 邮箱:hsaito@umaryland.edu
学习地点
-
-
Maryland
-
Baltimore、Maryland、美国、21231
- University of Maryland School of Dentistry
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age ≥18 years
- Male or Female
- Partially edentulous patients
- Healed ridges (≥3 months post-extraction with no history of socket preservation or ridge augmentation)
- Adequate bone volume (no need for major grafting)
- Sites requiring a single unit implant
- Provision of informed consent
Exclusion Criteria:
- Systemic or local disease or condition that would compromise bone metabolism, post-operative healing and/or osseointegration e.g. uncontrolled diabetes with self-reported most recent HbA1C > 8.0 within last six months
- Systemic corticosteroids or any other medication that would influence bone metabolism, post-operative healing, and/or osseointegration
- History of osseous degenerative diseases
- Heavy smoking (>10 cigarettes/day)
- Bisphosphonate/antiresorptive therapy
- uncontrolled periodontal disease
- Irradiated bone
- Previous history of failed implants
- Recently grafted/augmented site (< 1 year)
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:TiUnite
|
NobelReplace CC TiUnite dental implant placed according to the manufacturer's recommended surgical protocol. |
|
实验性的:TiUltra
|
NobelActive S TiUltra dental implant placed according to the manufacturer's recommended surgical protocol. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mean Implant Stability Quotient (ISQ) Measured by Resonance Frequency Analysis (RFA)
大体时间:Day 0 (implant placement) and Weeks 2, 4, 6, 8, and 12
|
Implant stability will be assessed using an Osstell device/SmartPeg transducer expressed as Implant Stability Quotient (ISQ) values on a scale of 0 to 100. Longitudinal changes in ISQ will be compared between the TiUnite and S-TiUltra implant groups over the 12-week healing period to evaluate differences in implant stability trajectories. |
Day 0 (implant placement) and Weeks 2, 4, 6, 8, and 12
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Mean Implant Insertion Torque (Ncm)
大体时间:Day 0 (during implant placement)
|
Insertion torque will be recorded during implant placement and expressed in Newton-centimeters (Ncm). |
Day 0 (during implant placement)
|
|
Change From Baseline in Radiographic Marginal Bone Level (mm)
大体时间:Day 0 (baseline) and Weeks 6 and 12
|
Marginal bone levels in millimeters (mm) will be assessed using standardized periapical radiographs obtained at implant placement (baseline) and at 6 and 12 weeks after surgery. |
Day 0 (baseline) and Weeks 6 and 12
|
|
Number of Participants With Implant Failure
大体时间:From Day 0 (implant placement) through Week 12
|
Implant-related complications, including implant failure and marginal bone loss, will be assessed during the 12-week follow-up period. |
From Day 0 (implant placement) through Week 12
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.